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ABSTRACT
Mercury is a ubiquitous environmental toxicant that causes a wide range of adverse health effects in humans. Three forms of mercury 
exist: elemental, inorganic and organic. Each of them has its own profile of toxicity. The aim of the present study was to determine the 
effect of thimerosal, a topical antiseptic and preservative in vaccines routinely given to children, methyl mercury, and mercuric chlo-
ride on cellular viability measured by MTT in Jurkat T cells, a human T leukemia cell line. The treatment of Jurkat T cells with thimerosal 
caused a significant decrease in cellular viability at 1 μM (25%, p<0.05; IC50: 10 μM). Methyl mercury exhibited a significant decrease in 
cellular viability at 50 μM (33%, p<0.01; IC50: 65 μM). Mercuric chloride (HgCl2) did not show any significant change in cellular survival. 
Our findings showed that contrary to thimerosal and methyl mercury, mercuric chloride did not modify Jurkat T cell viability. 
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been used as a topical antiseptic and as a preservative in 
vaccines routinely given to children, including diphtheria-
tetanus-acellular pertussis (DTP), hepatitis B, and some 
Haemophilus influenzae type B (Goldman & Shannon, 
2001; Halsey, 1999; Pichichero et al., 2002). Thimerosal 
(as sodium ethylmercuric thiosalicylate) contains 49.6% 
mercury by weight and is metabolized to ethyl mercury 
and thiosalicylate. The normal dose of a pediatric vac-
cine contains about 12.5–25 μg of mercury per 0.5 ml. 
(No authors listed, AAP, 1999). Massive overdoses from 
inappropriate use of products containing thimerosal 
have resulted in toxic effects (Axton, 1972; Fagan et al., 
1977; Lowell et al., 1996; Matheson et al., 1980; Pelassy 
et al., 1994; Pfab et al., 1996). Inorganic mercury (I-Hg) 
compounds (as mercury salts) are also a significant source 
of mercury overexposure in both adults and children in 
some countries (Clarkson, 2002). Inorganic mercury 
compounds have been used for many years in numerous 
products, including various medications, germicidal 
soaps, teething powders, and skin lightening cream 
containing mercury (Clarkson, 2002). Many of these 
mercury-based products are still in use today (Geier et al., 
2010; Goldman & Shannon, 2001). In the present study, 
we evaluated the effect of thimerosal, methyl mercury and 
mercuric chloride (HgCl2) on the viability of Jurkat T cells 
Introduction
Mercury, one of the most widely diffused and hazard-
ous organ-specific environmental contaminants, exists 
in a wide variety of physical and chemical states, each 
with unique characteristics of target organ specificity 
(Aleo et al., 2002). Mercury occurs in three forms: the 
elemental or metallic form, inorganic salts, and organic 
compounds. The toxicity of mercury is complex and 
depends on the form of mercury, route of entry, dosage, 
and age at exposure (Clarkson, 1997). The organic form 
of mercury, mainly methyl mercury, is known to be more 
toxic than the inorganic form (Shenker et al., 1992). 
Chronic exposure to low levels of methyl mercury can 
modulate T- and B-cell functions (cytokine production, 
cell growth, and proliferation) and different cellular 
processes leading to apoptotic cell death (Makani et al., 
2002; Shenker et al., 1992). Ethyl mercury is an organic 
mercury compound, and in the form of thimerosal has 
Interdiscip Toxicol. 2012; Vol. 5(3): 159–161. 
doi: 10.2478/v10102-012-0026-1
Published online in:
www.intertox.sav.sk & www.versita.com/science/medicine/it/
Copyright © 2012 SETOX & IEPT, SASc.
This is an Open Access article distributed under the terms of the Creative Commons Attribu-
tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited.
ORIGINAL ARTICLE
160
Gianpaolo Guzzi, Paolo D. Pigatto, Francesco Spadari, Caterina A.M. La Porta
Mercury compounds and Jurkat cells 
ISSN: 1337-6853 (print version) | 1337-9569 (electronic version)
by (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay.
Methods
Cell culture 
Human T leukemic Jurkat cells were purchased from 
American Type Culture Center (ATCC no. TIB-152) 
(Rockville, MD, USA) and maintained in RPMI-1640 
medium supplemented with 10% fetal bovine serum, 1% 
glutamine, and 1% antibiotics/antimicotics (pen./strep.). 
The cells were grown at 37 °C in a humidified atmosphere 
of 5% CO2.
Mercury and its chemical compounds
Thimerosal (EtHg), methyl mercury (MeHg) and mercu-
ric chloride [(mercuric (II) chloride (HgCl2) also termed 
‘mercury two’)] were purchased from Sigma. PBS and 
water were used to dilute mercuric chloride (HgCl2) and 
thimerosal, respectively. Cells treated only with vehicles 
were used as controls. 
Cytotoxicity assay (MTT)
The principle behind this technique depends on the 
capacity of living cells to reduce tetrazolium salt 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] to a formazan crystal in their metabolizing 
mitochondria. The number of 1 × 104 cells/well Jurkat 
T cells (ATCC no. TIB-152) were seeded into 96 well 
plates and exposed to thimerosal, methyl mercury, and 
mercuric chloride (HgCl2) at concentrations of thi-
merosal (0.01-0.1-1-10-50-100-250 μM), methyl mercury 
(30-50-80-100-250 μM), and mercuric chloride (HgCl2 
(20-40-60-80-100 μM). The plates were incubated at 37 °C 
in a humidified atmosphere containing 5% CO2. After 48 
hours, the medium was discarded and 20 μl/well of MTT 
solution (5 mg/ml) was added and incubated for 3 hours 
at 37 °C (5% CO2). Finally, 20μl/well of isopropanol was 
added and the color intensity was read spectrophoto-
metrically at 590 nm using a Microplate Reader (Bio-Rad 
Model 550, California, USA). 
Statistical analysis 
The ANOVA one-way test was used to determine statisti-
cal significance. A p-value of less than 0.05 was considered 
to be statistically significant. 
Results
We exposed Jurkat T cells to thimerosal, methyl mercury 
and mercuric chloride in the concentrations reported 
in Figure 1 for 48 hours. Upon exposure to thimerosal, 
methyl mercury and mercuric chloride (HgCl2), the 
viability of cells was measured with MTT assay. As shown 
in Figure 1, the treatment of Jurkat T cells with thimerosal 
caused a significant decrease in cellular viability at 1μM 
(25%, p<0.05; IC50: 10 μM). Methyl mercury exhibited a 
significant decrease in cellular viability at 50 μM (33%, 
p<0.01; IC50: 65 μM). Finally, at all concentrations 
analyzed, mercuric chloride (HgCl2), did not show any 
significant change in cellular survival (Figure 1). 
Discussion
Mercury is ubiquitous in the environment and expo-
sure occurs from the use of mercury-containing dental 
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Figure 1. Viability of Jurkat cells determined by MTT-assay after 
exposure to thimerosal, methylmercury and mercury chloride. 
The data are expressed as mean ± SEM. Asterisks indicate sig-
nifi cant diff erences from control cells without treatment (n=3, 
*p<0.05; **p<0.01; ***p<0.001). Note, the x-axis is not a linear scale.
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amalgam, vaccine preservatives, and ingestion of fish 
containing high levels of methyl mercury (Counter & 
Buchanan, 2004; Krantz & Dorevitch, 2004; Ratcliffe et 
al., 1996). In the literature, however, there are few data 
showing the effect of organic and inorganic mercury on 
cell viability. Considerable concern has been expressed 
recently over the cumulative dose of ethyl mercury given 
to children through routine immunizations (Geier et 
al., 2010; Hornig et al., 2004). The source of mercury in 
vaccines is the antimicrobial preservative thimerosal, 
containing 49.9% mercury by weight. Our findings 
demonstrate that thimerosal at the concentration usually 
found in vaccines, affects significantly cellular viability. 
A recent paper showed that after thimerosal exposure at 
the same concentration as tested in the present study, a 
human glioblastoma cell line displayed a similar effect 
(James et al., 2005). On the other hand, the form of 
mercury that accumulates in the food chain is methyl 
mercury. Some people may be exposed to higher levels 
of mercury in the form of methyl mercury if they have 
a diet high in fish, shellfish, or marine mammals that 
come from mercury-contaminated waters. Colombo et 
al. (2004) determined the sensitivity of Jurkat T cells to 
up to 1μM of methyl mercury after 48 hours of exposure 
(Colombo et al., 2004). They found that cellular viability 
determined by MTT assay showed no toxic effects dur-
ing the first 48 hours, yet exposure for up to 72 hours 
caused a significant decrease in cellular viability at the 
higher dose of mercury (1 μM) (Pelassy et al., 1994). Our 
findings are in accordance with these data and show that 
organic mercury, such as methyl mercury and thimerosal, 
are more cytotoxic than inorganic mercury (as HgCl2). 
Experiments are in progress to ascertain the underlying 
mechanisms of ethyl mercury induced cell death. It has 
been proposed to induce depletion of thiol reserves (e.g.: 
GSH) and ROS damage, activating death-signaling path-
ways (Makani et al., 2002). A previous study showed that 
thimerosal was able to induce apoptosis and G2/M phase 
in human leukemia U937 cells (Woo et al., 2006). Finally, 
according to other authors (Bahia et al., 1999; Ogura et al., 
1996), methyl mercury showed a higher toxicity compared 
to mercuric chloride (HgCl2). Recently, mercuric chloride 
(HgCl2) was reported to affect the differentiative capacity 
instead of proliferation in neural stem cells (Cedrola et al., 
2003). Further studies will attempt to assess the possible 
effect of thimerosal as preservative in vaccines. Our data 
showed an effect of organic mercury on the viability of 
Jurkat T cells, suggesting a possible toxic effect of these 
compounds of mercury in vivo. 
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